ArticleJournal of gastrointestinal oncology2025

First-line PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for advanced esophageal and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis of randomized controlled trials.

Sijia Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.